NCT04214691View on ClinicalTrials.gov

A Study of Newly Formulated Tylenol Tablet (Acetaminophen) and Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 17, 2019

Primary Completion Date

January 16, 2020

Study Completion Date

February 7, 2020

Conditions
Healthy
Interventions
DRUG

Acetaminophen

Acetaminophen tablet will be administered orally in treatment sequence 1 and 2.

Trial Locations (1)

8779

H plus Yangji Hospital, Seoul

All Listed Sponsors
lead

Janssen Korea, Ltd., Korea

INDUSTRY

NCT04214691 - A Study of Newly Formulated Tylenol Tablet (Acetaminophen) and Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants | Biotech Hunter | Biotech Hunter